STAT3 activation is associated with cerebrospinal fluid interleukin-10 (IL-10) in primary central nervous system diffuse large B cell lymphoma

被引:0
|
作者
Takashi Mizowaki
Takashi Sasayama
Kazuhiro Tanaka
Katsu Mizukawa
Kumi Takata
Satoshi Nakamizo
Hirotomo Tanaka
Hiroaki Nagashima
Masamitsu Nishihara
Takanori Hirose
Tomoo Itoh
Eiji Kohmura
机构
[1] Kobe University Graduate School of Medicine,Department of Neurosurgery
[2] Nishi-Kobe Medical Center,Department of Neurosurgery
[3] Kobe University Hospital,Department of Pathology for Regional Communication
[4] Kobe University Hospital,Department of Diagnostic Pathology
来源
Journal of Neuro-Oncology | 2015年 / 124卷
关键词
Central nervous system; Diffuse large B-cell lymphoma; Cerebrospinal fluid; STAT3; IL-10; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
Signal transducers and activators of transcription 3 (STAT3) are activated by various cytokines and oncogenes; however, the activity and pathogenesis of STAT3 in diffuse large B cell lymphoma of the central nervous system have not been thoroughly elucidated. We investigated the phosphorylation levels of STAT3 in 40 specimens of primary central nervous system diffuse large B-cell lymphoma (PCNS DLBCL) and analyzed the association between phsopho-STAT3 (pSTAT3) expression and cerebrospinal fluid (CSF) concentration of interleukin-10 (IL-10) or IL-6. Immunohistochemistry and Western blot analysis revealed that most of the specimens in PCNS DLBCL expressed pSTST3 protein, and a strong phosphorylation levels of STAT3 was statistically associated with high CSF IL-10 levels, but not with CSF IL-6 levels. Next, we demonstrated that recombinant IL-10 and CSF containing IL-10 induced the phosphorylation of STAT3 in PCNS DLBCL cells. Furthermore, molecular subtype classified by Hans’ algorithm was correlated with pSTAT3 expression levels and CSF IL-10 levels. These results suggest that the STAT3 activity is correlated with CSF IL-10 level, which is a useful marker for STAT3 activity in PCNS DLBCLs.
引用
收藏
页码:165 / 174
页数:9
相关论文
共 50 条
  • [21] The diagnostic and prognostic value of interleukin-10 in cerebrospinal fluid for central nervous system lymphoma: a meta-analysis
    Wang, Li
    Luo, Lan
    Gao, Zhe
    Liu, Shu-Feng
    Liu, Cheng-Jun
    Ma, De-Xun
    Chen, Ji-Gang
    Cao, Wu-Rui
    Yin, Ai-Min
    Xu, Jia-Wen
    Wang, Song-Lei
    Zhuo, Du-Jun
    Geng, Bin
    Zhao, Sha-Sha
    Wang, Fei-Yan
    Yang, Nan
    Guan, Li-Xun
    Gu, Zhen-Yang
    Gao, Chun-Ji
    LEUKEMIA & LYMPHOMA, 2017, 58 (10) : 2452 - 2459
  • [22] INTRATHECAL SYNTHESIS OF INTERLEUKIN-10 (IL-10) IN VIRAL AND INFLAMMATORY DISEASES OF THE CENTRAL-NERVOUS-SYSTEM
    GALLO, P
    SIVIERI, S
    RINALDI, L
    YAN, XB
    LOLLI, F
    DEROSSI, A
    TAVOLATO, B
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1994, 126 (01) : 49 - 53
  • [23] Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system
    Baraniskin, Alexander
    Kuhnhenn, Jan
    Schlegel, Uwe
    Chan, Andrew
    Deckert, Martina
    Gold, Ralf
    Maghnouj, Abdelouahid
    Zoellner, Hannah
    Reinacher-Schick, Anke
    Schmiegel, Wolff
    Hahn, Stephan A.
    Schroers, Roland
    BLOOD, 2011, 117 (11) : 3140 - 3146
  • [24] NK Cell IL-10 Production Requires IL-15 and IL-10 Driven STAT3 Activation
    Clark, Sarah E.
    Burrack, Kristina S.
    Jameson, Stephen C.
    Hamilton, Sara E.
    Lenz, Laurel L.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [25] Cerebrospinal Fluid IL-6 Plus IL-10 As Effective Diagnostic Biomarkers for Secondary Central Nervous System Lymphoma
    Gu, Jiayan
    Jin, Jie
    BLOOD, 2023, 142
  • [26] THE COMBINATION OF INTERLEUKIN-10 AND BETA2-MICROGLOBULIN IN CEREBROSPINAL FLUID IS A USEFUL BIOMARKER IN IMMUNOCOMPETENT PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
    Sasayama, Takashi
    Tanaka, Kazuhiro
    Nakamizo, Satoshi
    Nishihara, Masamitsu
    Tanaka, Hirotomo
    Mizukawa, Katsu
    Kohmura, Eiji
    NEURO-ONCOLOGY, 2013, 15 : 151 - 151
  • [27] Exploring the diagnostic potential of cerebrospinal fluid (CSF) IL-10:IL-6 ratio in patients with primary central nervous system lymphoma (PCNSL)
    Singh, Sofia
    Kapila, Aastha Takkar
    Prakash, Gaurav
    Lal, Vivek
    Gupta, Vishali
    Minz, Ranjana Walker
    Mahesh, Karthik Vinay
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [28] Primary Central Nervous System Lymphoma: Diffuse Large B-Cell Lymphoma
    Ali, Asuman
    Haki, Cemile
    Atalay, Fatma Oz
    Yalcin, Ramazan
    TURKISH JOURNAL OF NEUROLOGY, 2019, 25 (04) : 239 - 242
  • [29] IL-10 INDUCES STAT1 AND STAT3 ACTIVATION IN CELLS
    WEBERNORDT, RM
    GREENLUND, AC
    DARNELL, JE
    SCHREIBER, RD
    BLOOD, 1994, 84 (10) : A223 - A223
  • [30] Cerebrospinal fluid IL-6 and IL-10 as promising diagnostic and therapeutic prognostic biomarkers for secondary central nervous system lymphoma
    Gu, Jiayan
    Huang, Xin
    Zhang, Yi
    Bao, Chenhui
    Zhou, Ziyang
    Tong, Hongyan
    Jin, Jie
    BMC CANCER, 2024, 24 (01)